Standout Papers
Citation Impact
Citing Papers
Antibiotics induce redox-related physiological alterations as part of their lethality
2014
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
2009
Topographical and Temporal Diversity of the Human Skin Microbiome
2009 StandoutScience
Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis
2006
Identification of an N -Acetylglucosamine Transporter That Mediates Hyphal Induction in Candida albicans
2006
The Shared Antibiotic Resistome of Soil Bacteria and Human Pathogens
2012 Science
Plants send small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes
2018 StandoutScience
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection
2007
Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men
2008
Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils
2005
Community-Acquired Methicillin-Resistant Staphylococcus aureus Emerging as an Important Cause of Necrotizing Fasciitis
2008
The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis
2016
Molecular Epidemiology of Community-Associated Antimicrobial-Resistant Staphylococcus aureus in Seoul, Korea (2003): Pervasiveness of Multidrug-Resistant SCC mec Type II Methicillin-Resistant S. aureus
2007
Characterization of Staphylococcus aureus Nasal Carriage from Children Attending an Outpatient Clinic in Seoul, Korea
2008
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Epidemiology and risk factors for Staphylococcus aureuscolonization in children in the post-PCV7 era
2009
Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of TH-17 Responses
2010
Community-associated Methicillin-resistant Staphylococcus aureus: Overview and Local Situation
2006
National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft-Tissue Infections
2008
New advances in antibiotic development and discovery
2005
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Community-associated methicillin-resistant Staphylococcus aureus: risk factors for infection, and long-term follow-up
2009
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Modelling an outbreak of an emerging pathogen
2007
Antimicrobial Activity of Community-associated Methicillin-resistant Staphylococcus aureus Is Caused by Phenol-soluble Modulin Derivatives
2011
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
2009
Advances in combating fungal diseases: vaccines on the threshold
2006
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2014
Vulvovaginal candidosis
2007 Standout
Necrotizing Soft-Tissue Infection: Diagnosis and Management
2007
Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003–2006
2011
Eschar with Cellulitis as a Clinical Predictor in Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Skin Abscess
2008
Methicillin-Resistant Staphylococcus aureus as a Common Cause of Vulvar Abscesses
2008
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
2007
Community-acquired methicillin-resistant Staphylococcus aureus infections
2006
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
2011
Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
2008
Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
2009
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients
2006
Methicillin‐Resistant Staphylococcus aureus in a Canadian Intensive Care Unit: Delays in Initiating Effective Therapy Due to the Low Prevalence of Infection
2007
An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients
2002
Community-associated meticillin-resistant Staphylococcus aureus
2010
Health Care-Associated Pneumonia (HCAP)
2011
An insight into the antifungal pipeline: selected new molecules and beyond
2010
Panton-Valentine Leukocidin Facilitates the Escape of Staphylococcus aureus From Human Keratinocyte Endosomes and Induces Apoptosis
2013
Emergence of the USA300 Strain of Methicillin-Resistant Staphylococcus aureus in a Burn-Trauma Unit
2008
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
2013
Community-associated MRSA: What makes them special?
2013
Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa
2006
An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report
2008
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Is Panton–Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?
2007
Community-associated meticillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK
2009
What Antimicrobial Resistance Has Taught Us About Horizontal Gene Transfer
2009
Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA)
2007
Community-Associated Strains of Methicillin-ResistantStaphylococccus aureusas the Cause of Healthcare-Associated Infection
2006
Increase of the USA300 Clone Among Community-Acquired Methicillin-Susceptible Staphylococcus aureus Causing Invasive Infections
2007
Immunotherapy for Fungal Infections
2006
Lack of development of new antimicrobial drugs: a potential serious threat to public health
2005
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
2008
Differentiating Between Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Osteomyelitis in Children
2011
Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety
2012
Antimicrobial drug development – the past, the present, and the future
2004
Fatal Brain Abscess due to Community-Associated Methicillin-Resistant Staphylococcus aureus Strain USA300
2007
Panton-Valentine leukocidin-producing Staphylococcus aureus infections: Report of 4 French cases
2006
Therapy for fungal diseases: opportunities and priorities
2010
Methicillin-SusceptibleStaphylococcus aureusin Skin and Soft Tissue Infections, Northern Italy
2009
Effects of Linezolid on Suppressing In Vivo Production of Staphylococcal Toxins and Improving Survival Outcomes in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia
2013
Methicillin-ResistantStaphylococcus aureusin a Beauty Salon, the Netherlands
2008
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
A Geographic Variant of theStaphylococcus aureusPanton‐Valentine Leukocidin Toxin and the Origin of Community‐Associated Methicillin‐ResistantS. aureusUSA300
2008
Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection With Fatal Necrotizing Pneumonia From Lip Abscess: A Case Report
2007
Staphylococcus aureus skin/soft-tissue infections: The impact of SCCmec type and Panton-Valentine leukocidin
2008
The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal CassettemecLinkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐ResistantStaphylococcus aureus
2008
Defining and combating antibiotic resistance from One Health and Global Health perspectives
2019
Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
2005
In Vitro Production of Panton-Valentine Leukocidin among Strains of Methicillin-Resistant Staphylococcus aureus Causing Diverse Infections
2007
High diversity of Panton–Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus
2007
Population Dynamics of Nasal Strains of Methicillin‐ResistantStaphylococcus aureus—and Their Relation to Community‐Associated Disease Activity
2005
Emergence of Community-Associated Methicillin-ResistantStaphylococcus aureusInfection Among Patients With End-Stage Renal Disease
2006
Dynamical features of thePlasmodium falciparumribosome during translation
2015 StandoutNobel
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Staphylococcus aureus Panton-Valentine Leukocidin Contributes to Inflammation and Muscle Tissue Injury
2009
Toll-like receptors in the induction of the innate immune response
2000 StandoutNature
Concurrent Epidemics of Skin and Soft Tissue Infection and Bloodstream Infection Due to Community-Associated Methicillin-Resistant Staphylococcus aureus
2012
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
2008
Community-Onset Methicillin-Resistant Staphylococcus aureus Skin and Soft-Tissue Infections: Impact of Antimicrobial Therapy on Outcome
2007
The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300
2008
Missed epidural brain abscess after furunculosis
2008
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus
2006
Identification of Anti-virulence Compounds That Disrupt Quorum-Sensing Regulated Acute and Persistent Pathogenicity
2014
The role of virulence determinants in community-associated MRSA pathogenesis
2008
Community-Acquired Methicillin-Resistant Staphylococcus Aureus As a Cause of Fournier’s Gangrene
2008
Modeling the Invasion of Community‐Acquired Methicillin‐Resistant Staphylococcus aureus into Hospitals
2009
A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
2011
Community‐Associated Methicillin‐ResistantStaphylococcus aureusand HIV: Intersecting Epidemics
2010
Antibiotic resistance increases with local temperature
2018
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
2008
Cutaneous Community‐associated Methicillin‐resistant Staphylococcus aureus among All Skin and Soft‐tissue Infections in Two Geographically Distant Pediatric Emergency Departments
2006
Infective Pyomyositis and Myositis in Children in the Era of Community‐Acquired, Methicillin‐ResistantStaphylococcus aureusInfection
2006
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections
2009
Spread of methicillin‐resistant Staphylococcus aureus USA300 in a neonatal intensive care unit
2008
Skin and Soft‐Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship
2010
Epidemiology and Clinical Manifestations of Mucormycosis
2012
Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital
2007
Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections
2006
Ophthalmic Manifestations of Infections Caused by the USA300 Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus
2006
Has the era of untreatable infections arrived?
2009
Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment.
2001
The Evolution of Fungicide Resistance
2014
Staphylococcus aureusSepsis and the Waterhouse–Friderichsen Syndrome in Children
2005
Impact of Antibiotics on Expression of Virulence‐Associated Exotoxin Genes in Methicillin‐Sensitive and Methicillin‐ResistantStaphylococcus aureus
2006
Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?
2008
Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied use
2006
Staphylococcus aureus α-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic Cells
2009
COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NECROTIZING FASCIITIS IN A NEONATE
2006
New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good
2011
Nurturing scientific mutualism: A report from the ‘Young Microbiologists Mini‐Symposium on microbe signalling, organisation and pathogenesis’
2009
Comparison of Both Clinical Features and Mortality Risk Associated with Bacteremia due to Community-Acquired Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus
2008
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
2006
Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents
2007
The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study
2012
Community‐Associated Strains of Methicillin‐ResistantStaphylococcus aureusand Methicillin‐SusceptibleS. aureusin Indigenous Northern Australia: Epidemiology and Outcomes
2009
Iron in Infection and Immunity
2013
The Inflammasomes
2010 Standout
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
MRSA with progression from otitis media and sphenoid sinusitis to clival osteomyelitis, pachymeningitis and abducens nerve palsy in an immunocompetent 10-year-old patient
2008
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications
2008
New antimicrobial agents as therapy for resistant gram-positive cocci
2007
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections
2005
Mechanisms of Candida albicans Trafficking to the Brain
2011
Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors
2008
Changing Patterns of Acute Hematogenous Osteomyelitis and Septic Arthritis
2006
Is Panton‐Valentine Leukocidin the Major Virulence Determinant in Community‐Associated Methicillin‐Resistant Staphylococcus aureus Disease?
2006
Platforms for antibiotic discovery
2013
Fungal vaccines: real progress from real challenges
2008
Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection
2007
Staphylococcus aureusBloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006
2008
A 20-year retrospective review of global aquaculture
2021 StandoutNature
Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseases
2011
Immunity to fungal infections
2011 Standout
The Scourge of Antibiotic Resistance: The Important Role of the Environment
2013
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
2010
Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium
2005
Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment
2009
Cryo-EM structure of a type IV secretion system
2022 StandoutNatureNobel
Prevalence of USA300 Colonization or Infection and Associated Variables During an Outbreak of Community‐Associated Methicillin‐Resistant Staphylococcus aureus in a Marginalized Urban Population
2007
Bacterial phylogeny structures soil resistomes across habitats
2014 Nature
Bacterial Resistance and Impetigo Treatment Trends: A Review
2012
The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis
2012
Roles of 34 Virulence Genes in the Evolution of Hospital‐ and Community‐Associated Strains of Methicillin‐Resistant Staphylococcus aureus
2006
Clinical features and molecular characteristics of invasive community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children
2007
Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections
2008
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Skin and Soft-Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureus
2007
IL-22 defines a novel immune pathway of antifungal resistance
2010
Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum
2006
Increasing Incidence of Sterile-Site Infections Due to Non-Multidrug-Resistant, Oxacillin-Resistant Staphylococcus aureus Among Hospitalized Patients
2007
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
2014
Staphylococcus aureus α-Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome
2012
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
2006
Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infections in Children
2006
Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens
2012
Risk Factors and Molecular Analysis of Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Colonization in Healthy Children
2008
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
2011
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Community Associated Methicillin Resistant Staphylococcus Aureus Causing Fournier’s Gangrene and Genital Infections
2007
The changes of MRSA infections in chronic suppurative otitis media
2008
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
2012
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Malaria: Mechanisms of Erythrocytic Infection and Pathological Correlates of Severe Disease
2006
Predominance of Methicillin-Resistant Staphylococcus aureus among Pathogens Causing Skin and Soft Tissue Infections in a Large Urban Jail: Risk Factors and Recurrence Rates
2008
A Prospective Investigation of Outcomes after Hospital Discharge for Endemic, Community-Acquired Methicillin-Resistant and -Susceptible Staphylococcus aureus Skin Infection
2007
Melioidosis: Epidemiology, Pathophysiology, and Management
2005 Standout
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
1999 StandoutScience
Invasive Fungal Pathogens: Current Epidemiological Trends
2006
Phenotypic Prediction Rule for Community-Associated Methicillin-Resistant Staphylococcus aureus
2007
Antimicrobial Susceptibility Patterns and Staphylococcal Cassette Chromosome mec Types of, as Well as Panton-Valentine Leukocidin Occurrence among, Methicillin-Resistant Staphylococcus aureus Isolates from Children and Adults in Middle Tennessee
2006
Antibiotic resistance is ancient
2011 StandoutNature
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains ofPseudomonas aeruginosa
2010
Candida guilliermondii , an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program
2006
Is the GAIN Act a turning point in new antibiotic discovery?
2013
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
2018
Are RNA Viruses Candidate Agents for the Next Global Pandemic? A Review
2017
Successful Multiresistant Community-Associated Methicillin-Resistant Staphylococcus aureus Lineage from Taipei, Taiwan, That Carries Either the Novel Staphylococcal Chromosome Cassette mec (SCC mec ) Type V T or SCC mec Type IV
2005
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Targeted metabolic labeling of yeast N-glycans with unnatural sugars
2010 StandoutNobel
Cutaneous Community-associated Methicillin-resistant Staphylococcus aureus among All Skin and Soft-tissue Infections in Two Geographically Distant Pediatric Emergency Departments
2007
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Epidemiology and Outcomes of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
2007
Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns
2007
The Genomic Enzymology of Antibiotic Resistance
2010
Osmosensory signaling in Mycobacterium tuberculosis mediated by a eukaryotic-like Ser/Thr protein kinase
2013 StandoutNobel
Community Strains of Methicillin-ResistantStaphylococcus aureusas Potential Cause of Healthcare-associated Infections, Uruguay, 2002–2004
2008
Presence and Molecular Epidemiology of Virulence Factors in Methicillin-Resistant Staphylococcus aureus Strains Colonizing and Infecting Soldiers
2009
Interleukin-12 in infectious diseases
1997
New Targets and Screening Approaches in Antimicrobial Drug Discovery
2005
Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community.
2007
Fungal cell wall vaccines: an update
2012
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
2018 StandoutScience
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections
2012
Community acquired methicillin resistant Staphylococcus aureus: A Wisconsin perspective.
2006
Staphylococcus aureus comunitario resistente a cloxacilina: Comunicación de los primeros cinco casos descritos en Chile
2008
Invasive Infections with Community-Associated Methicillin-Resistant Staphylococcus aureus after Kidney Transplantation
2008
Molecular Mechanisms of Antibacterial Multidrug Resistance
2007
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
2007
Unraveling the Physiological Complexities of Antibiotic Lethality
2014
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination
2009
Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children
2006
The soil resistome: a critical review on antibiotic resistance origins, ecology and dissemination potential in telluric bacteria
2014
Sporadic “Transitional” Community-Associated Methicillin-Resistant Staphylococcus aureus Strains from Health Care Facilities in the United States
2007
Emerging Targets in Photopharmacology
2016 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
1999 Science
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Toll‐like receptors: molecular mechanisms of the mammalian immune response
2000
Unconventional screening approaches for antibiotic discovery
2015
The impact of training informal health care providers in India: A randomized controlled trial
2016 StandoutScienceNobel
Towards an integrated model of bacterial conjugation
2014
Fresh Approaches to Anti-Infective Therapies
2012
Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting
2010
Activity of Daptomycin Alone and in Combination with Rifampin and Gentamicin against Staphylococcus aureus Assessed by Time-Kill Methodology
2007
Candida rugosa , an Emerging Fungal Pathogen with Resistance to Azoles: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program
2006
Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa
2015 StandoutNobel
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Hidden Killers: Human Fungal Infections
2012 Standout
Plant and Animal Sensors of Conserved Microbial Signatures
2010 StandoutScienceNobel
Acute rise in methicillin‐resistant Staphylococcus aureus infections in a coastal community
2007
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
2005
Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections
2006
Challenges of Antibacterial Discovery
2011
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Health Care Competition and Antibiotic Use in T aiwan
2015
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of Brad Spellberg being referenced
The Anti- Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis
2006
Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
2009
The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus
2008
The future of antibiotics
2014
Antibody Titer Threshold Predicts Anti‐Candidal Vaccine Efficacy Even though the Mechanism of Protection Is Induction of Cell‐Mediated Immunity
2008
Progress Toward a Staphylococcus aureus Vaccine
2011
Trends in Antimicrobial Drug Development: Implications for the Future
2004
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles
2005
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
2010
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
2007
Novel antipsychotics and new onset diabetes
1998
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials
2009
Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis
2008
Mice with Disseminated Candidiasis Die of Progressive Sepsis
2005
Type 1/Type 2 Immunity in Infectious Diseases
2001
Current Treatment Strategies for Disseminated Candidiasis
2005
Seven Ways to Preserve the Miracle of Antibiotics
2013
Immunological Reactivity of Blood from Healthy Humans to the rAls3p‐N Vaccine Protein
2009
Clinical and Epidemiologic Characteristics Cannot Distinguish Community-Associated Methicillin-Resistant Staphylococcus aureus Infection from Methicillin-Susceptible S. aureus Infection: A Prospective Investigation
2007
Vaccines for invasive fungal infections
2011
Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6
2004
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy.
1997
The pathophysiology and treatment of Candida sepsis
2002
Combination Therapy for Mucormycosis: Why, What, and How?
2012
Efficacy of the Anti‐CandidarAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis
2006
Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
2009
Novel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies
2015
Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community‐Acquired Pneumonia
2008
The Anti- Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice
2005
Vaccination with Recombinant N-Terminal Domain of Als1p Improves Survival during Murine Disseminated Candidiasis by Enhancing Cell-Mediated, Not Humoral, Immunity
2005
Voriconazole Use for Endemic Fungal Infections
2009
Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole
1994
Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
2005
Caspofungin Inhibits Rhizopus oryzae 1,3-β- d -Glucan Synthase, Lowers Burden in Brain Measured by Quantitative PCR, and Improves Survival at a Low but Not a High Dose during Murine Disseminated Zygomycosis
2005